POLR3A and systemic sclerosis: Indeed, the POLR3A locus, coding for the antigenic target of ARA, was altered in cancer tissue specimens from SSc patients carrying ARA, leading to the synthesis of an immunogenic enzyme resulting in T-cell-driven ARA production and SSc onset [49].